INFY » Topics » 1.19 Stock-based compensation

This excerpt taken from the INFY 6-K filed Jul 28, 2005.

1.19    Stock-based compensation

                 The company applies the intrinsic value-based method of accounting prescribed by Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations including FASB Interpretation No. 44, Accounting for Certain Transactions involving Stock Compensation an interpretation of APB Opinion No. 25, issued in March 2000, to account for its fixed stock option plans. Under this method, compensation expense is recorded on the date of grant only if the current market price of the underlying stock exceeds the exercise price. SFAS 123, Accounting for Stock-Based Compensation, established accounting and disclosure requirements using a fair value-based method of accounting for stock-based employee compensation plans. As allowed by SFAS 123, the Company has elected to continue to apply the intrinsic value-based method of accounting described above, and has adopted the disclosure requirements of SFAS 148, Accounting for Stock-Based Compensation – Transition and Disclosure, an amendment of FASB Statement No. 123. All stock options issued to date have been accounted as a fixed stock option plan.

                 The following table illustrates the effect on net income and earnings per share if the company had applied the fair value recognition provisions of SFAS Statement No. 123, Accounting for Stock-Based Compensation, to stock-based employee compensation.

 
 

Three months ended June 30,

 
 
 
(Dollars in millions except per share data) 2004   2005  
 
 
 
Net income, as reported $ 83   $ 122  
 Deduct: Total stock-based employee compensation expense
    determined under fair value based method for all awards,
    net of related tax effects
  (9 )   (4 )
 
 
 
Pro forma net income $ 74   $ 118  
 
 
 
Earnings per share:            
     Basic – as reported $ 0.31   $ 0.45  
     Basic – pro forma $ 0.28   $ 0.44  
     Diluted – as reported $ 0.31   $ 0.43  
     Diluted – pro forma $ 0.28   $ 0.42  
 
 
 
 

                 There have been no grants of stock options by Infosys Technologies Limited during the three months ended June 30, 2004 and 2005.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki